An infernal cross‐talk between oncogenic β‐catenin and c‐Met in hepatocellular carcinoma: Evidence from mouse modeling
Rosa M. Pascale, Francesco Feo, Diego F. Calvisi – 6 September 2016
Scorecard and insights from approaches to liver allocation around the world
Phillip Dutkowski, Pierre A. Clavien – 6 September 2016
Does timing of rearterialization of liver grafts affect biliary complications in living and deceased donor liver transplantation?
Ashwin Rammohan, Sanjay Govil, Mohamed Rela – 4 September 2016
Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
Suman Verma, Fiona Hand, Matthew J. Armstrong, Marie Vos, Douglas Thorburn, Terry Pan, John Klinck, Rachel H. Westbrook, Georg Auzinger, Andrew Bathgate, Steven Masson, Andrew Holt, Diarmaid D. Houlihan, James W. Ferguson – 4 September 2016 – Liver transplantation (LT) in patients with portopulmonary hypertension (PoPH) has historically resulted in unpredictable and often poor outcomes. The United Kingdom experience for the period 1992‐2012 is reported in this article.
Novel approaches and therapeutics in acute‐on‐chronic liver failure
Rajiv Jalan – 2 September 2016
Strategies for minimizing immunosuppression: State of the Art
Alberto Sanchez‐Fueyo – 2 September 2016
The evolving role of the microbiome in liver failure and liver transplantation
Kymberly D. Watt – 2 September 2016
“In 10 years” debate: Con—machine perfusion will be limited to specific situations (Steatotic, donation after circulatory death)
Juan Echeverri, Markus Selzner – 2 September 2016
Surgical advances in obese candidates and recipients
Julie Heimbach – 30 August 2016
HBV therapeutic vaccines and cccDNA inhibitors – emergence of a cure
James Fung – 30 August 2016